Qube Research & Technologies (QRT)
CGTX icon

Qube Research & Technologies (QRT)’s Cognition Therapeutics CGTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1K Buy
+21,800
New +$25.8K ﹤0.01% 3205
2026
Q1 		– Sell
-17,078
Closed -$23.1K – 3587
2025
Q4 		$23.1K Buy
+17,078
New +$27.7K ﹤0.01% 3370
2024
Q2 		– Sell
-2,121
Closed -$3.86K – 3891
2024
Q1 		$3.86K Buy
+2,121
New +$4.38K ﹤0.01% 3922

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CGTX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Cognition Therapeutics (CGTX) in Q2 2026: 21,800 shares worth $25.1K. The stake represents ﹤0.01% of the portfolio and ranks #3205 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in CGTX as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in CGTX in Q1 2024 and has held it in 3 quarters since. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 21,800 shares of Cognition Therapeutics worth $25.1K as of Q2 2026.
  • Cognition Therapeutics was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Cognition Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3205 holding.
  • Qube Research & Technologies (QRT) first reported a position in Cognition Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.